SI
BSX icon

Sava Infond’s Boston Scientific BSX Stock Holding History

Sava Infond’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.71M Buy
87,020
+41,910
+93% +$2.28M 0.26% 64
2026
Q1 		$2.83M Sell
45,110
-6,880
-13% -$550K 0.4% 58
2025
Q4 		$4.96M Sell
51,990
-930
-2% -$91.2K 0.67% 27
2025
Q3 		$5.17M Sell
52,920
-950
-2% -$98.4K 0.73% 26
2025
Q2 		$5.79M Buy
53,870
+6,560
+14% +$664K 0.9% 23
2025
Q1 		$4.77M Sell
47,310
-2,000
-4% -$201K 0.91% 26
2024
Q4 		$4.4M Buy
+49,310
New +$4.34M 0.78% 29

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Sava Infond's BSX Position: Q2 2026 in Review

Sava Infond increased its Boston Scientific (BSX) stake by 93% in Q2 2026, buying an estimated $2.28M and bringing the position to 87,020 shares worth $3.71M. The position accounts for 0.26% of the portfolio, ranked #64.

Sava Infond first reported a position in BSX in Q4 2024 and has held it in 7 quarters since. The position peaked at $5.79M in Q2 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Sava Infond held 87,020 shares of Boston Scientific worth $3.71M as of Q2 2026.
  • Sava Infond bought 41,910 Boston Scientific shares in Q2 2026, an estimated $2.28M.
  • Boston Scientific made up 0.26% of Sava Infond's portfolio in Q2 2026, its #64 holding.
  • Sava Infond first reported a position in Boston Scientific in Q4 2024 and has held it in 7 quarters since.
  • Sava Infond's Boston Scientific position peaked at $5.79M in Q2 2025.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Sava Infond's 13F filing for Q2 2026, filed 16 Jul 2026.